Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply

Monica S M Persson; Aliya Sarmanova; Michael Doherty; Weiya Zhang

doi:10.1093/rheumatology/key269

Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply

Monica S M Persson, Aliya Sarmanova, Michael Doherty, Weiya Zhang

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

2 Citations (Scopus)

154 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Article number	key269
Pages (from-to)	2060-2061
Number of pages	2
Journal	Rheumatology
Volume	57
Issue number	11
Early online date	10 Sept 2018
DOIs	https://doi.org/10.1093/rheumatology/key269
Publication status	Published - Nov 2018

Access to Document

10.1093/rheumatology/key269

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Oxford University Press at https://doi.org/10.1093/rheumatology/key269 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 58.9 KB

Handle.net

Persistent link

Embargoed Document

Full-text PDF (final published version)
Final published version, 69.6 KB

Cite this

@article{bb2e40e80f2343ae9c838a03bfcc0eac,

title = "Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply",

abstract = "[no abstract]",

author = "Persson, \{Monica S M\} and Aliya Sarmanova and Michael Doherty and Weiya Zhang",

year = "2018",

month = nov,

doi = "10.1093/rheumatology/key269",

language = "English",

volume = "57",

pages = "2060--2061",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "11",

}

Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply. / Persson, Monica S M; Sarmanova, Aliya; Doherty, Michael et al.
In: Rheumatology, Vol. 57, No. 11, key269, 11.2018, p. 2060-2061.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Comment on

T2 - Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply

AU - Persson, Monica S M

AU - Sarmanova, Aliya

AU - Doherty, Michael

AU - Zhang, Weiya

PY - 2018/11

Y1 - 2018/11

N2 - [no abstract]

AB - [no abstract]

U2 - 10.1093/rheumatology/key269

DO - 10.1093/rheumatology/key269

M3 - Article (Academic Journal)

C2 - 30204904

SN - 1462-0324

VL - 57

SP - 2060

EP - 2061

JO - Rheumatology

JF - Rheumatology

IS - 11

M1 - key269

ER -

Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply

Abstract

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this